Drugs Used in Heart Failure

by Mukhtar, Sumbal

Pharmacology

Your browser is too old

We can't provide a great video experience on old browser

Update now
Uc1iqllyq32lp6wxwuag 180825 s0 mukhtar sumbal drugs used in heart failure intro
03:20
Drugs Used in Heart Failure
Rejablh4tc2zaplqpppr 180825 s1 mukhtar sumbal heart failure
12:09
Heart Failure
C9ybchmqckbkrupx53q8 180825 s2 mukhtar sumbal positive inotropic drugs
12:30
Positive Inotropic Drugs
Gqqcvkhq3a5ddaivtsmn 180825 s3 mukhtar sumbal drugs without positive inotropic agents
11:04
Drugs Without Positive Inotropic Agents
Um6cmydtreqpzf5iygnm 180825 s4 mukhtar sumbal clinical pharmacology of drugs
10:35
Clinical Pharmacology of Drugs
S1vyrhmslcf1q8t01xcq 180825 s5 mukhtar sumbal management of heart failure
09:59
Management of Heart Failure

Lecture´s Description

Heart Failure
In this lecture ´´Drugs Used in Heart Failure´´ are explained. Section one is about ´´Heart Failure´´. Educator gives overview of heart failure. Then clinical classification is described. Following this systolic vs. diastolic is exhibited diagrammatically. After that systolic vs. diastolic is comparatively discussed. Moving onward, pathophysiology of heart failure is elaborated. Subsequently compensatory mechanisms are pursued. Lastly, sign and symptoms of HF are reported.


Positive Inotropic Drugs
Section two is about ‘’Positive Inotropic Drugs’’. Earlier in this section, pharmacology of drugs used in heart failure is discussed. Then cardiac glycosides are explained.  This is followed by cardiac effects. Moving onward, effects on other organs are reported. Afterward, information is conveyed about interactions with K, Ca and Mg. Then bipyridines are focused. Likewise, bipyridines-pharmacodynamics is elaborated. Next, beta-adrenoceptor agonist comes under consideration. Furthermore, dobutamine is discussed in this section. In the end, investigational positive inotropic drugs are highlighted.


Drugs Without Positive Inotropic Agents
Section three is about ‘’Drugs Without Positive Inotropic Agents’’. Educator's prime focus in this section is drugs without positive inotropic effects.  After that diuretics are elucidated. Then complication of diuretics is reported. Following this, spironolactone is discussed. Likewise, ACE inhibitors are pursued. Furthermore, angiotensin receptor blockers are elaborated. Vasodilators are also discussed in this section. At last, educator reveals information about beta-adrenoceptor blockers.


Clinical Pharmacology of Drugs
Section four is about ‘’Clinical Pharmacology of Drugs’’. Educator begins with elucidation of vasodilators. Then beta blockers and ion channel blockers are illustrated. This is followed by ion channel blockers. After that digitalis is explained. Educator reports other clinical uses of digitalis. Moreover, digoxin toxicity is highlighted. Then digoxin-causes of toxicity are elaborated.


Management of Heart Failure
Section five is about ‘’Management of Heart Failure’’. Educator’s first theme under discussion is classification of heart failure. Then management of acute heart failure is elaborated. This is followed by explanation of management of chronic heart failure. At last, difference between HF and HA is highlighted.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

100% satisfaction guaranteed, join us & boost your medical Knowledge